TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma
Abroad (travel likely)RecruitingPHASE1
Conditions
Advanced Malignant Solid Neoplasm · Metastatic Malignant Solid Neoplasm · Metastatic Pancreatic Adenocarcinoma · Refractory Pancreatic Adenocarcinoma · Stage III Pancreatic Cancer AJCC v8 · Stage IV Pancreatic Cancer AJCC v8 · Unresectable Malignant Solid Neoplasm · Unresectable Pancreatic Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
Contact: Study coordinator (Office of Clinical Research) · OCRReferral@health.ucdavis.edu · 916-382-6970Contact: Principal Investigator (Edward J. Kim, MD, PhD)
Study leads
Edward J Kim, MD, PhD
Principal Investigator
University of California, Davis